MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Corticosteroids"

  • 2024 International Congress

    The Role of Cortisol a Mediator in Influencing Cognitive Function

    DT. Akramova (Tashkent, Uzbekistan)

    Objective: To explore cortisol's impact on cognitive decline and life quality in Parkinson's disease (PD) Background: PD patients exhibit varied symptoms, including cognitive deficits and…
  • 2024 International Congress

    Broadening the Spectrum of Movement Disorders in Steroid-responsive Encephalopathy associated with Autoimmune Thyroiditis

    M S. Majoul, R. Zouari, A. Rachdi, M Z. Saied, D. Ben Mohamed, F. Nabli, S. Ben Sassi (Tunis, Tunisia)

    Objective: To describe clinical and paraclinical spectrum of Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT) in a Tunisian cohort. Background: SREAT is a heterogenous group…
  • 2023 International Congress

    refractory myoclonus after COVID-19 with resolution after corticosteroids; a case report with brain biopsy and serial neuroimaging.

    E. Marandi, M. Gates, H. Patel, P. Hanna, W. Ma (Edison, USA)

    Objective: To present an individual with multifocal myoclonus after COVID-19 infection with resolution of bilateral MRI hyperintensities following corticosteroids use. Background: Myoclonus after Covid-19 infection…
  • MDS Virtual Congress 2021

    IMMUNE-MEDIATED MOVEMENT DISORDERS: CLINICAL MANIFESTATIONS, TREATMENT, AND EVOLUTION. A MULTICENTER STUDY

    M. Bala, F. Gonzalez, M. Saucedo, L. Bandeo, A. Chertcoff, L. de Francesco, G. Napoli, L. Leon Cejas, P. Bonardo, N. Morera, L. Tschopp, C. Rugilo, C. Calandra, A. Pellene, G. Raina, Z. Salazar, G. Rinaldi, P. Judewicz, J. Rivas, J. Gustavo Jose, D. Ballesteros, M. Tela, F. Gualtieri, J. Amor, C. Esliman, F. Caiza Zambrano, T. Arakaki, N. Garretto, S. Rodriguez, A. Kohler, A. Laffue, O. Martinez, M. Fernandez Pardal, R. Reisin, C. Uribe Roca (Caba, Argentina)

    Objective: To evaluate the clinical characteristics, etiologies, treatment, and evolution of patients with immune-mediated movement disorders(IMMD). Background: The highly variable and complex phenomenology of IMMD and…
  • MDS Virtual Congress 2020

    Secondary Vascular Parkinsonism: Role of increasing levels cortisol in the cognitive impairment

    D. Akramova (Tashkent, Uzbekistan)

    Objective: Elevated cortisol levels are found in many diseases, including infectious, related to aging, depression, and associated with a depressive status. Elevated cortisol levels are…
  • MDS Virtual Congress 2020

    Endocrine Predicts of the Formation of Complex Motor Tics in Tourette’s Disease

    D. Labunskiy, E. Yurasova, N. Kurgaev, S. Kiryukhina, V. Podsevatkin, D. Baranov (Saransk, Russian Federation)

    Objective: Our data show that increasing plasma concentrations of the hormone of the stress-implementing system-cortisol, as well as dysfunctional disorders of the hormonal status characterizing…
  • 2019 International Congress

    A case of cerebellar ataxia caused by Pembrolizumab for Non-small cell lung cancer

    T. Moto, H. Nagayama, K. Kimura (Tokyo, Japan)

    Objective: We reported a case that cerebellar ataxia and decreased accumulation of right cerebellum at SPECT appeared after immunotherapy using immune-checkpoint inhibitor “Pembrolizumab” for Non-small…
  • 2019 International Congress

    Steroid responsive chorea in Moyamoya disease: illustrative cases

    S. Medarametla, N. Boraiah, S. Swamy, S. Raju (Bangalore, India)

    Objective: To report the rapid reduction of disabling chorea in two cases of pediatric Moyamoya disease with pulse steroid therapy. Background: The common clinical presentation…
  • 2019 International Congress

    Alleviation of Parkinson’s and Associated Depression using Silymarin in Rotenone induced Mice Model of Parkinson’s Disease

    D. Khatri (Pune, India)

    Objective: The present study was undertaken in order find out the possible neuroprotective and antidepressant potential of Silymarin. The neuroprotective and antidepressant potential was evaluated…
  • 2018 International Congress

    Dopaminergic impairments following repeated exposure to stress on the neurotoxicity of lambda-cyhalothrin through inflammatory cytokines in rats

    R. Shukla, R. Gupta, S. Goel, A. Pant, V. Khanna (Bhopal, India)

    Objective: Impact of psychological stressors in modulating the toxicity of environmental chemicals has been suggested, however the mechanism this is not clear. Background: Repeated stress…
  • 1
  • 2
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley